Effects of Desflurane-Induced Preconditioning Following Ischemia-Reperfusion
on Modulation of Calcium Homeostasis in Rat Heart by 諛뺤쑄怨� & �쑄寃쎈큺
1139
Tissue Engineering and Regenerative Medicine, Vol. 6, No. 12,  pp 1139-1147 (2009)                                                                                                             
｜Original Article｜
Effects of Desflurane-Induced Preconditioning Following Ischemia-Reperfusion 
on Modulation of Calcium Homeostasis in Rat Heart
Hyun-Soo Kim
1
, Wyun-Kon Park
2
* and Kyung-Bong Yoon
2
*
1
Brain Korea 21 Project for Medical Science, College of Medicine, Yonsei University, 134, Shinchon-Dong, 
Seodaemun-Gu, Seoul, 120-752 Korea, 
2
Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute,
College of Medicine, Yonsei University, 134, Shinchon-Dong, Seodaemun-Gu, Seoul, 120-752 Korea
(Received: August 11
th
, 2009; Accepted: August 13
th
, 2009)
Abstract : Ca
2+ 
overload induced by ischemia-reperfusion alters Ca
2+
 homeostasis, which plays an important role
in myocardial cell injury. Although desflurane has been commonly used in anesthesia, little is known about its car-
dioprotective effect associated with Ca
2+
 homeostasis in ischemia-reperfused rat heart. Artificially ventilated anaes-
thetized Sprague-Dawley rats were subjected to a 30 min of left anterior descending coronary artery occlusion
followed by 2 h of reperfusion. Rats were randomly assigned to one of three groups; Sham, I/R only, desflurane pre-
conditioning group. In the present study, desflurane reduced infarct size (43.6±5.5% vs. 19.1±1.9% for I/R and des-
flurane, respectively, p<0.01). In desflurane-treated rat heart, we observed a consistent decrease in the expression of
pro-apoptotic protein Bax leading to a decrease in cytochrome c release. We also found that desflurane enhanced
expression of anti-apoptotic protein Bcl-2, activated ERK concerned with survival, and significantly attenuated
abnormal changes of sarcoplasmic reticulum genes and proteins in ischemia-reperfused rat heart. These results sug-
gest that desflurane prevents myocardial injury in response to ischemia-reperfusion by modulating sarcoplasmic
reticulum function.
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1. Introduction
Ischemia-reperfusion (I/R) injury in myocardium triggers
stress signaling processes that eventually results in cell death
and myocardial damage.
1,2
 A proposed underlying mechanism
include intracellular Ca
2+ 
overload as a consequence of
dysregulation of Ca
2+
 homeostasis, which has been proposed as
an important therapeutic target for increasing the tolerance to I/
R injury.
3
 In attempt to lessen the I/R injury, ischemic
preconditioning has been introduced as an effective treatment
modality.
4
 Ischemic preconditioning is an endogenous
phenomenon whereby repeated brief episodes of coronary
artery occlusion protect the heart against further prolonged
ischemia.
5
 Interestingly, it has been shown that certain
anesthetic agents such as volatile anesthetics and opioids
possess cardioprotective effects against I/R injury, mimicking
ischemic preconditioning.
6-9
 Anesthetic agents appear to
prevent the accumulation of intracellular Ca
2+
 that occurs
during myocardial hypoxia or ischemia and may induce cell
apoptosis leading to cardiomyopathy and heart failure.
10-12
Therefore, the interruption of Ca
2+ 
overload has been proposed
as an important target for increasing tolerance to I/R injury. 
Volatile anaesthetics induce cardioprotective effects through
signal transduction pathways similar to those observed during
ischemic preconditioning such as activation of protein kinase
C, mitochondrial adenosine triphosphate-regulated potassium
channels, and reactive oxygen species.
13-15
 Among volatile
anesthetic agents, desflurane has been shown to confer
cardioprotection against I/R injury, which mimics ischemic
preconditioning effects.
16-21
 However, evidence is lacking
regarding I/R injury associated with Ca
2+
 homeostasis. The aim
of this study was to determine whether desflurane protects
myocardium against I/R injury by regulating Ca
2+ 
homeostasis
by measuring myocardial infarct size, the expression of
proteins involved in survival signals, apoptosis, and the
expression of genes and proteins influencing Ca
2+
 homeostasis.
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2. Materials and Methods
2.1 Animal Preparation
Animal experimental procedures were approved by the
committee for the Care and Use of Laboratory Animals, Yonsei
University College of Medicine and were performed in
accordance with the Committee’s Guidelines and Regulations
for Animal Care. Male Sprague-Dawley rats (250-300 g) were
anesthetized with a single i.p. injection of pentobarbital 60 mg
kg
-1
. After tracheal intubation, the rats were artificially
ventilated (Harvard Apparatus 683, MA, USA) with oxygen
100%. A heparinized catheter was inserted into the right
femoral artery for continuous monitoring of mean aortic
pressure, and a Lead-II electrocardiogram monitored heart rate
via subcutaneous stainless steel electrodes connected to a
PowerLab monitoring system (ML845 PowerLab with
ML132; AD Instruments, CO, USA). The tail vein was
cannulated to infuse saline. Rectal temperature was maintained
at 38
o
C during the entire experiment using a heating pad
connected to a rectal probe.
2.2 Experimental Protocol
After a left thoracotomy and pericardiotomy, the heart was
exposed and a suture was passed around the left anterior
descending (LAD) coronary artery by inserting a small curved
Prolene 6.0 needle into the margin of the pulmonary cone,
exiting through the middle of a line linking the cone to the
atrium. The suture ends were threaded through a small vinyl
tube to prepare a snare. The LAD coronary artery was occluded
for 30 min by tightening the snare. Myocardial ischemia was
confirmed by the appearance of a regional cyanosis on the
epicardium distal to the snare and akinesia or bulging in this
area. After a 30 min ischemia, the snare was released and
reperfused for a period of 2 h. The thread passed around the
LAD coronary artery was left in place. Hemodynamic
parameters were measured at the following time points; (1)
20 min before desflurane treatment (baseline), (2) at the end of
desflurane treatment (or no treatment), 3) at the end of ischemia
(or no ischemia), and (4) at the end of reperfusion (2 h).
2.3 Study Groups
Rats were randomly assigned to one of the three treatment
groups (n = 10 for each group, Fig. 1) and received 30 min of
occlusion followed by 2 h reperfusion. The groups were as
follows. ‘I/R’: rats did not receive desflurane treatment during
the entire experiment; ‘Desflurane’: rats were subjected to
inhalation of desflurane for 20 min before 30 min of occlusion
followed by 10 min washout. Desflurane 5.7%, corresponding
to 1 MAC in rat,
22
 was delivered in oxygen (100%, flow rate: 2
L/min) through desflurane vaporizer (Devapor Type M32600,
Dräger AG, Germany). The end-tidal concentrations of
desflurane were monitored with a gas analyzer (Capnomac,
Datex, Helsinki, Finland) that had been calibrated before use.
Sham rats were treated similarly except that the coronary suture
was not tied and desflurane was not administered.
Figure 1. Occlusion of the left anterior descending (LAD) coronary artery was maintained for 30 min followed by reperfusion. After 2 h,
sampling was performed for measurement of infarct size, immunoblot, and RT-PCR, respectively. I/R, ischemia/reperfusion group; Des-
flurane, desflurane administered during the preconditioning period; Sham, the coronary suture was not tied and desflurane was not
administered. MAC: minimum alveolar concentration.
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2.4 Measurement of Infarct Size
At the end of the 2 h reperfusion period, the heart was excised
and immersed in 2% triphenyltetrazolium chloride (TTC)
(Sigma Chemicals, MO, USA) for 20 min at 37
o
C. The
infarcted myocardium, which does not take up TTC stain when
the dehydrogenase enzymes are drained off, remains pale in
color. The hearts were sliced and photographed, and infarct size
was determined by dividing the total necrotic area of the left
ventricle by the total left ventricular area.
23
 The boundary of
unstained area was traced in a blinded fashion and quantified
with NIH image, version 1.61.
2.5 Immunoblot Analysis
At the end of the 2 h reperfusion period, tissue preparation
was performed as previously described.
24
 Briefly, tissue
specimens were pulverized and dissolved in lysis buffer (Cell
Signaling, MA, USA). The solution was vigorously
homogenized with Pyrex Potter-Elvehjem Tissue Grinder
(BLD Science, NC, USA) and centrifuged at 12,000×g for 10
min at 4
o
C. The supernatant was transferred to a new tube and
stored at -70
o
C. Protein concentrations were determined using
the Bradford protein assay kit (BioRad, CA, USA). Proteins
were separated in a 12% SDS-polyacrylamide gel and
transferred to PVDF membrane (Millipore Co, MA, USA).
After blocking the membrane with Tris-buffered saline-Tween
20 (TBS-T, 0.1% Tween 20) containing 5% non-fat dried milk
for 1 h at room temperature, membranes were washed twice
with TBS-T and incubated with primary antibodies for 1 h at
room temperature or overnight at 4
o
C. The following primary
antibodies were used: rabbit anti-extracellular signal-regulated
kinases (ERK), mouse anti-phospho ERK, mouse anti-Bcl-2,
mouse anti-Cytochrome C, goat anti-rat sarcoplasmic
reticulum Ca
2+
-ATPase (SERCA2), mouse phospholamban
(PLB), rabbit calsequestrin (CSQ), anti-ryanodine receptor
(RyR), phosphorylated PLB at serine-16 (Ser), phosphorylated
PLB at threonine-17 (Thr) (Santa Cruz Biotechnology, CA,
USA), rabbit anti-Bax (Assay Designs, MI, USA), and mouse
anti-β-actin antibodies (Sigma Chemicals, MO, USA). The
membranes were washed three times with TBS-T for 10 min,
and then incubated for 1 h at room temperature with
horseradish peroxidase (HRP)-conjugated secondary
antibodies. After extensive washing, bands were detected by
enhanced chemiluminescence (ECL) reagent (Santa Cruz
Biotechnology, CA, USA). β-actin gene was used as the
standard for equalizing the protein samples. The band
intensities were quantified using NIH image, version 1.61.
Each experiment was performed at least three times.
2.6 RT-PCR Analysis
Tissue samples were vigorously homogenized with Pyrex
Potter-Elvehjem Tissue Grinder (BLD Science, NC, USA) in
TRI Reagent (Sigma Chemicals, MO, USA). Total RNA was
prepared using the UltraspectTM-II RNA system(Biotecx
Laboratories, Inc., TX, USA) and single-stranded cDNA was
synthesized from isolated total  RNA using avian
Myeloblastosis virus (AMV) reverse transcriptase. A 20 µl
reverse transcription reaction mixture containing 1 g of total
RNA, 1X reverse transcription buffer (10 mM Tris-HCl, pH
9.0, 50 mM KCl, 0.1% Triton X-100), 1 mM deoxynucleoside
triphosphates (dNTPs), 0.5 unit of RNase inhibitor, 0.5 g of
oligo (dT)15, and 15 units of AMV reverse transcriptase was
incubated at 42
o
C for 15 min, heated to 99
o
C for 5 min, and
then incubated at 0-5
o
C for 5 min. All primer pairs for DNA
sequence of proteins related to calcium homeostasis are shown
in Table 1. PCR conditions were 94
o
C for 3 min, 94
o
C for 1
min, 41-49
o
C for 1 min and 72
o
C for 2 min, 35 cycles, with a
final extension for 10 min at 72
o
C. GAPDH gene (primers 5'-
accacagtccatgccatcac-3' and 5'-tccaccaccctgttgctgta-3', 450 bp)
was used as the internal standard. The signal intensity of the
amplification product was analyzed using the UVlband
Table 1. The nucleotide sequence of all primer pairs for proteins related to Ca
2+ 
homeostasis.
Genes Primer sequence Size (bp)
L-type Ca
2+
-channel
Na
+
-Ca
2+
 exchanger
SR Ca
2+
-ATPase
Phospholamban
Ryanodine receptor 2
Calsequestrin
Sense: 5- TGTCACGGTTGGGTAGTGAA-3
Antisense: 5’-TTGAGGTGGAAGGGACTTTG-3’
Sense: 5-TGTCTGCGATTGCTTGTCTC-3
Antisense: 5-TCACTCATCTCCACCAGACG-3
Sense: 5-TCCATCTGCCTGTCCAT-3
Antisense: 5-GCGGTTACTCCAGTATTG-3
Sense: 5-GCTGAGCTCCCAGACTTCAC-3
Antisense: 5-GCGACAGCTTGTCACAGAAG-3
Sense: 5-CCAACATGCCAGACCCTACT-3
Antisense: 5-TTTCTCCATCCTCTCCCTCA-3
Sense: 5-TCAAAGACCCACCCTACGTC-3
Antisense: 5-CCAGTCTTCCAGCTCCTCAG-3
346
364
196
339
351
352
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software (UVltec, Cambridge, UK).
2.7 Statistical Analysis
Data analysis was performed using the statistical software
program Prism v3.0 (GraphPad Software, USA). Comparisons
among multiple groups were performed using one-way
ANOVA (Analysis of Variance) with Bonferroni’s test. Data
are presented as mean±SD or SEM of more than three separate
experiments performed in triplicate. Statistical significance was
defined as p<0.05.
3. Results
3.1 Hemodynamics and Measurement of Infarct Size
The heart rate and mean arterial pressure are summarized in
Table 2. The mean arterial pressure during the preconditioning
period in desflurane group was significantly lower (p<0.05)
than that of the baseline value. The other values of mean arterial
pressure and heart rate revealed no differences in either inter- or
intragroup comparisons. Infarct sizes are shown in figure 2.
Mean infarct size of the left ventricle in the I/R group was 43.6
±5.5%. In the desflurane-treated group, infarct sizes of the left
ventricle were significantly reduced to 19.1±1.9% (p<0.01).
3.2 Western Blot Analysis on Phosphorylation of ERK
and Apoptosis Proteins
The activation of extracellular signal-regulated kinases (ERK
1/2) plays an important role in the mechanisms of cellular
survival and proliferation through gene regulation.
25
 ERK 1/2
are dual specificity mitogen-activated protein (MAP) kinase
and we measured phosphorylation of ERK (42 and 44 kDa) by
immunoblot assay. The phosphorylation activity of ERK was
dramatically lower in I/R group than in sham group. Rats
treated with desflurane showed significantly higher levels of
ERK activity than those in the I/R group (Fig. 3). Ischemia and
Table 2. Hemodynamic parameters
Baseline Preconditioning Ischemia Reperfusion
HR MAP HR MAP HR MAP HR MAP
I/R
Desflurane
435±52 139±6 434±50 137±9 444±45  121±10 451±42 114±6
425±45 134±8 401±43  89±9* 457±42 117±6 439±33 101±9
Data are mean±SD. HR, heart rate (beats per min); MAP, mean arterial pressure (mmHg). I/R, ischemia/reperfusion; Desflurane, desflurane
administered during the preconditioning period. * Significantly (P<0.05) different from baseline.
Figure 2. Infarct size was analyzed using planar morphometry in
2,3,5-triphenyltetrazolium (TTC) stained sections and expressed
as a ratio of the left ventricular area. I/R, ischemia/reperfusion
group; Desflurane, desflurane administered during the precondi-
tioning period. Each value is the mean±SEM of 10 hearts/group.
Differences were considered statistically significant when
*p<0.05 vs. I/R group.
Figure 3. Western blot analysis measuring ERK and p-ERK. Each
signal was quantified by scanning densitometry. I/R, ischemia/
reperfusion group; Desflurane, desflurane administrated during
the preconditioning period; Sham, the coronary suture was not
tied and desflurane was not administered. Each value is the mean
±SEM of 10 hearts/group. Differences were considered statisti-
cally significant when *p<0.05, **p<0.01.
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reperfusion increased expression of pro-apoptotic proteins such
as Bcl-2-associated X protein (Bax) and cytochrome c and
decreased expression of the anti-apoptotic protein, B cell
leukemia/lymphoma-2 (Bcl-2) (Fig. 4). In the desflurane-
treated group, the expression levels of Bax and cytochrome c
were decreased, whereas the expression level of Bcl-2 was
Figure 4. Western blot analysis measuring Bcl-2, Bax, and cytochrome c. Each signal was quantified by scanning densitometry. β-actin
was used as an internal standard. I/R, ischemia/reperfusion group; Desflurane, desflurane administered during the preconditioning
period; Sham, the coronary suture was not tied and desflurane was not administered. Each value is the mean±SEM of 10 hearts/group.
Differences were considered statistically significant when *p<0.05, **p<0.01.
Figure 5. Analysis of the expressions of genes related to Ca
2+
 homeostasis. (A), Representative gel image of mRNA levels. B-G: Histo-
grams of SERCA2a (B), phospholamban (C), ryanodine receptor 2 (D), calsequestrin (E), L-type Ca
2+
-channel (F), and Na
+
-Ca
2+
exchanger (NCX) (G). GAPDH was used as an internal standard. I/R, ischemia/reperfusion group; Desflurane, desflurane administrated
during the preconditioning period; Sham, the coronary suture was not tied and desflurane was not administered. Each value is the mean
± SEM of 10 hearts/group. Differences were considered statistically significant when *p<0.05, **p<0.01.
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increased when compared to that of the I/R group.
3.3 Expression of Genes and Proteins Influencing
Calcium Homeostasis
In order to assess gene expressions related to Ca
2+
homeostasis, total RNA was isolated and analyzed by semi-
quantitative RT-PCR. The levels of gene expression for
sarcoplasmic reticulum (SR) proteins such as SERCA2a, PLB,
RyR
2
, and CSQ were decreased in I/R rat heart, while treatment
with desflurane resulted in upregulation of mRNA transcription
levels for SR proteins. However, L-type Ca
2+
 channels and Na
+
-
Ca
2+
exchanger (NCX) were unaltered by ischemia-reperfusion
with or without desflurane administration (Fig. 5). To further
confirm the functional changes of SR proteins related to
alteration of mRNA expression, we examined protein levels of
SERCA2a, PLB, RyR, and CSQ. Most SR proteins were
decreased in I/R group but restored in the desflurane-treated
group (Fig. 6). These results are in agreement with changes
seen in mRNA transcription levels. Although PLB protein
contents were unaltered, all phosphorylated PLB proteins
normalized to total PLB were increased in desflurane-treated
group (Fig. 7), indicating that PLB in I/R hearts were
predominantly in the unphosphorylated form.
4. Discussion
In this study, we observed a significant reduction in ischemia-
reperfusion induced myocardial infarct size in the desflurane-
treated group.  Our resul ts  demonstrated that  the
cardioprotective effect of desflurane occurs in association with
modulation of proteins involved in Ca
2+
 homeostasis. Several
studies have reported that desflurane decreased infarct size in
various experimental models and species.
16-18
 Here, we also
confirmed that desflurane-induced preconditioning
dramatically reduced myocardial infarct size. Desflurane has
been reported more cardioprotective than the other volatile
anesthetics.
16
ERK 1/2 are members of the mitogen-activated protein
(MAP) kinase-family of serine-threonine kinases involved in
regulating cell proliferation, differentiation and survival. ERK
1/2 are activated in response to ischemia-reperfusion, oxidative
stress, hypoxia, and adrenergic stimulation,
25
 and mediate
cellular protection during ischemia-reperfusion.
26
 Our results
demonstrated that desflurane activates ERK and maintains
viability in rat heart exposed to ischemia-reperfusion, similar to
that reported previously.
21,27
 In response to an apoptotic
stimulus such as I/R, the pro-apoptotic protein, Bax, undergoes
Figure 6. Western blot analysis of SR proteins. Each signal was quantified by scanning densitometry. β-actin was used as an internal
standard. I/R, ischemia/reperfusion group; Desflurane, desflurane administrated during the preconditioning period; Sham, the coronary
suture was not tied and desflurane was not administered. Each value is the mean±SEM of 10 hearts/group. Differences were considered
statistically significant when *p<0.05, **p<0.01.
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a conformational change that allows it to translocate to the
mitochondria where it induces cytochrome c release. In
addition, activation of ERK 1/2 inhibits conformational change
in Bax protein and cytochrome c-induced caspase activation,
thereby preventing apoptosis.
28
 The anti-apoptotic protein Bcl-
2 has been identified in the outer mitochondrial membrane and
is known to attenuate cellular injury by inhibiting cytochrome c
translocation, preventing injurious Ca
2+
 release from the
endoplasmic reticulum
29
 and inhibiting Bax translocation from
the cytoplasm to the mitochondria.
30
 During ischemic
preconditioning, an increase in Bcl-2 in association with a
decrease in the pro-apoptotic protein Bax has been reported in
isolated rat heart.
31
 In the present study, we observed an
increase in expression of the anti-apoptotic protein Bcl-2, a
decrease in the expression of the pro-apoptotic protein Bax as
well as attenuation of mitochondrial cytochrome c release,
which indicate that desflurane induces a cardioprotective effect
against apoptosis caused by I/R.
Ca
2+ 
is an important messenger in intracellular signal
transduction and plays an important role in cardiac excitation-
contraction coupling.
32
 During the process of excitation-
contraction coupling, intracellular Ca
2+
 homeostasis is carefully
regulated by ion channels, specific binding and transport
proteins. It has been proposed that changes in Ca
2+
 homeostasis
play an important role in modulation of apoptosis,
33 
and the
balance between Bcl-2 and Bax affects mitochondrial
Ca
2+
homeostasis, which is important in determining whether
cells survive or undergo apoptosis. Therefore, intracellular
dysregulation of Ca
2+
 homeostasis has been proposed as one of
the mechanisms of cell injury induced by I/R.
SR plays a central role in regulating intracellular Ca
2+
concentration and contains SR Ca
2+
-cycling proteins such as
RyR, SERCA2a, PLB, and CSQ. The reduced expression of SR
gene in I/R rat heart in our study was in accordance with a
previous finding that expression of SR gene is markedly
decreased in I/R.
34
 We also found that treatment with desflurane
restored the level of SR gene expression. In addition, our results
regarding expression of SR proteins were in accordance with
those seen for SR genes. These results indicate that desflurane
modulates SR gene expression in ischemia-reperfused rat heart.
Although the expression of SR genes was increased by
antioxidants and ß-adrenergic receptor blockers,
34,35
 further
studies are needed to investigate the transcription mechanism
regulating the expression of SR gene by desflurane.
36
 Previous
reports have concluded that reduced PLB phosphorylation in I/
R is related to reduced SR Ca
2+ 
uptake,
37-39
 thus, the increase in
PLB phosphorylation in desflurane-treated rat may be
responsible for recovery of SERCA2a activity. Ca
2+
 entry
across the membrane through L-type Ca
2+
 channels is balanced
by an efflux of Ca
2+
 from Na
+
-Ca
2+
 exchanger (NCX).
31
 In this
study, we found that transcription levels of L-type Ca
2+
channels and NCX were not altered, similar to our previous
study on propofol.
40
 In contrast, increases in NCX expression
were reported in various animal models of heart failure.
41-43
Therefore, we suggest that it may be dependent on animal
species and experimental conditions. 
In conclusion, desflurane confers protection against injury in
ischemia-reperfused rat heart. Furthermore, changes in SR
proteins related to Ca
2+
 homeostasis are attenuated by
desflurane, which produce a cardioprotective effect as a result
Figure 7. Western blot analysis of PLB-Ser and PLB-Thr. Each signal was quantified by scanning densitometry. Total PLB was used as
an internal standard. I/R, ischemia/reperfusion group; Desflurane, desflurane administered during the preconditioning period; Sham, the
coronary suture was not tied and desflurane was not administered. Each value is the mean±SEM of 10 hearts/group. Differences were
considered statistically significant when *p<0.05, **p<0.01.
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of reduction of apoptotic cell death.
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